{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:16:55Z","timestamp":1784254615765,"version":"3.55.0"},"reference-count":179,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Alpha-calcitonin gene-related peptide (\u03b1-CGRP) is a vasodilator neuropeptide of the calcitonin gene family. Pharmacological and gene knock-out studies have established a significant role of \u03b1-CGRP in normal and pathophysiological states, particularly in cardiovascular disease and migraines. \u03b1-CGRP knock-out mice with transverse aortic constriction (TAC)-induced pressure-overload heart failure have higher mortality rates and exhibit higher levels of cardiac fibrosis, inflammation, oxidative stress, and cell death compared to the wild-type TAC-mice. However, administration of \u03b1-CGRP, either in its native- or modified-form, improves cardiac function at the pathophysiological level, and significantly protects the heart from the adverse effects of heart failure and hypertension. Similar cardioprotective effects of the peptide were demonstrated in pressure-overload heart failure mice when \u03b1-CGRP was delivered using an alginate microcapsules-based drug delivery system. In contrast to cardiovascular disease, an elevated level of \u03b1-CGRP causes migraine-related headaches, thus the use of \u03b1-CGRP antagonists that block the interaction of the peptide to its receptor are beneficial in reducing chronic and episodic migraine headaches. Currently, several \u03b1-CGRP antagonists are being used as migraine treatments or in clinical trials for migraine pain management. Overall, agonists and antagonists of \u03b1-CGRP are clinically relevant to treat and prevent cardiovascular disease and migraine pain, respectively. This review focuses on the pharmacological and therapeutic significance of \u03b1-CGRP-agonists and -antagonists in various diseases, particularly in cardiac diseases and migraine pain.<\/jats:p>","DOI":"10.3389\/fphys.2022.826122","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T09:46:44Z","timestamp":1644572804000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Alpha-Calcitonin Gene Related Peptide: New Therapeutic Strategies for the Treatment and Prevention of Cardiovascular Disease and Migraine"],"prefix":"10.3389","volume":"13","author":[{"given":"Ambrish","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maelee","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald J.","family":"DiPette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay D.","family":"Potts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11325","DOI":"10.1074\/jbc.271.19.11325","article-title":"A cDNA encoding the calcitonin gene-related peptide type 1 receptor.","volume":"271","author":"Aiyar","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S1474-4422(20)30282-9","article-title":"Targeting CGRP in migraine: a matter of choice and dose.","volume":"19","author":"Al-Hassany","year":"2020","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"H1525","DOI":"10.1152\/ajpheart.00874.2012","article-title":"Inotropic and lusitropic effects of calcitonin gene-related peptide in the heart.","volume":"304","author":"Al-Rubaiee","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/298240a0","article-title":"Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products.","volume":"298","author":"Amara","year":"1982","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1476-5381.1993.tb13460.x","article-title":"Effect of bradykinin and prostaglandins on the release of calcitonin gene-related peptide-like immunoreactivity from the rat spinal cord in vitro.","volume":"108","author":"Andreeva","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.7.2.3","article-title":"Encapsulated cell technology-based delivery of a complement inhibitor reduces choroidal neovascularization in a mouse model.","volume":"7","author":"Annamalai","year":"2018","journal-title":"Transl. Vis. Sci. Technol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1742-7843.2004.pto940606.x","article-title":"Effects of the calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS on alpha-CGRP-induced regional haemodynamic changes in anaesthetised rats.","volume":"94","author":"Arulmani","year":"2004","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1111\/ene.14715","article-title":"Long-term efficacy and safety of erenumab in migraine prevention: results from a 5-year, open-label treatment phase of a randomized clinical trial.","volume":"28","author":"Ashina","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/0333102420905132","article-title":"Eptinezumab in episodic migraine: a randomized, double-blind, placebo-controlled study (PROMISE-1).","volume":"40","author":"Ashina","year":"2020","journal-title":"Cephalalgia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/circulationaha.117.028388","article-title":"A novel alpha-calcitonin gene-related peptide analogue protects against end-organ damage in experimental hypertension, cardiac hypertrophy, and heart failure.","volume":"136","author":"Aubdool","year":"2017","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.567","article-title":"Population pharmacokinetic and exposure-response analysis of eptinezumab in the treatment of episodic and chronic migraine.","volume":"8","author":"Baker","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"key":"B12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.regpep.2004.03.016","article-title":"Aldosterone modulates neural vasomotor response in hypertension: role of calcitonin gene-related peptide.","volume":"120","author":"Balfagon","year":"2004","journal-title":"Regul. Pept."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2210-6-9","article-title":"Identification of specific calcitonin-like receptor residues important for calcitonin gene-related peptide high affinity binding.","volume":"6","author":"Banerjee","year":"2006","journal-title":"BMC Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1006\/jmcc.1995.0231","article-title":"Hypertrophic effects of calcitonin gene-related peptide (CGRP) and amylin on adult mammalian ventricular cardiomyocytes.","volume":"27","author":"Bell","year":"1995","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-021-02678-8","article-title":"Myocardial perfusion recovery induced by an alpha-calcitonin gene-related peptide analogue.","author":"Bentsen","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/s0167-0115(02)00100-3","article-title":"Role of calcitonin gene-related peptide (CGRP) in chronic hypoxia-induced pulmonary hypertension in the mouse. Influence of gene transfer in vivo.","volume":"108","author":"Bivalacqua","year":"2002","journal-title":"Regul. Pept."},{"key":"B17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/s0165-5728(01)00475-1","article-title":"NGF modulates CGRP synthesis in human B-lymphocytes: a possible anti-inflammatory action of NGF?","volume":"123","author":"Bracci-Laudiero","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/313054a0","article-title":"Calcitonin gene-related peptide is a potent vasodilator.","volume":"313","author":"Brain","year":"1985","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1021\/bi00216a036","article-title":"Solution structure of human calcitonin gene-related peptide by 1H NMR and distance geometry with restrained molecular dynamics.","volume":"30","author":"Breeze","year":"1991","journal-title":"Biochemistry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/s0022-5347(05)68047-0","article-title":"Autoradiographic localization of tachykinin and calcitonin gene-related peptide receptors in adult urinary bladder.","volume":"163","author":"Burcher","year":"2000","journal-title":"J. Urol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/j.1526-4610.2009.01523.x","article-title":"Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan.","volume":"49","author":"Cady","year":"2009","journal-title":"Headache"},{"key":"B22","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.1021\/bi0102860","article-title":"Turn structures in CGRP C-terminal analogues promote stable arrangements of key residue side chains.","volume":"40","author":"Carpenter","year":"2001","journal-title":"Biochemistry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"E331","DOI":"10.1152\/ajpendo.1989.256.2.E331","article-title":"Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37).","volume":"256","author":"Chiba","year":"1989","journal-title":"Am. J. Physiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1177\/41.10.8245413","article-title":"Distribution of calcitonin gene-related peptide in vertebrate neuromuscular junctions: relationship to the acetylcholine receptor.","volume":"41","author":"Csillik","year":"1993","journal-title":"J. Histochem. Cytochem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S0006-291X(02)00487-4","article-title":"Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure.","volume":"294","author":"Cueille","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e2211","DOI":"10.1212\/WNL.0000000000006640","article-title":"Galcanezumab in chronic migraine: the randomized, double-blind, placebo-controlled REGAIN study.","volume":"91","author":"Detke","year":"2018","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00000441-198902000-00001","article-title":"Dose-dependent systemic and regional hemodynamic effects of calcitonin gene-related peptide.","volume":"297","author":"DiPette","year":"1989","journal-title":"Am. J. Med. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S1474-4422(14)70128-0","article-title":"Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.","volume":"13","author":"Dodick","year":"","journal-title":"Lancet Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S1474-4422(14)70209-1","article-title":"Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.","volume":"13","author":"Dodick","year":"","journal-title":"Lancet Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1001\/jama.2018.4853","article-title":"Effect of fremanezumab compared with placebo for prevention of episodic migraine: a randomized clinical trial.","volume":"319","author":"Dodick","year":"2018","journal-title":"JAMA"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.14670\/HH-16.1073","article-title":"Synthesis of calcitonin gene-related peptide (CGRP) by rat arterial endothelial cells.","volume":"16","author":"Doi","year":"2001","journal-title":"Histol. Histopathol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/0306-4522(92)90237-v","article-title":"Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo.","volume":"49","author":"Donnerer","year":"1992","journal-title":"Neuroscience"},{"key":"B33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1749-6632.1992.tb22814.x","article-title":"Evidence for an increase in the release of CGRP from sensory nerves during inflammation.","volume":"657","author":"Donnerer","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/sj.bjp.0703110","article-title":"Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist.","volume":"129","author":"Doods","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/0002-9149(92)90736-i","article-title":"Effects of calcitonin gene-related peptide on cardiac contractility, coronary hemodynamics and myocardial energetics in idiopathic dilated cardiomyopathy.","volume":"70","author":"Dubois-Rande","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010342","article-title":"TRP channels in the focus of trigeminal nociceptor sensitization contributing to primary headaches.","volume":"21","author":"Dux","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/head.13081","article-title":"The trigeminovascular pathway: role of CGRP and CGRP receptors in migraine.","volume":"57","author":"Edvinsson","year":"2017","journal-title":"Headache"},{"key":"B38","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/apha.12213","article-title":"Differential localization and characterization of functional calcitonin gene-related peptide receptors in human subcutaneous arteries.","volume":"210","author":"Edvinsson","year":"2014","journal-title":"Acta. Physiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.mcn.2010.10.005","article-title":"Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat.","volume":"46","author":"Edvinsson","year":"2011","journal-title":"Mol. Cell. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0304-3940(85)90166-1","article-title":"Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat.","volume":"58","author":"Edvinsson","year":"1985","journal-title":"Neurosci. Lett."},{"key":"B41","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the target of new migraine therapies \u2013 successful translation from bench to clinic.","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-12-112","article-title":"Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level.","volume":"12","author":"Eftekhari","year":"2011","journal-title":"BMC Neurosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.neuroscience.2010.05.016","article-title":"Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion.","volume":"169","author":"Eftekhari","year":"2010","journal-title":"Neuroscience"},{"key":"B44","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jpain.2013.03.010","article-title":"Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system.","volume":"14","author":"Eftekhari","year":"2013","journal-title":"J. Pain"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1210\/en.2011-1459","article-title":"Direct interactions between calcitonin-like receptor (CLR) and CGRP-receptor component protein (RCP) regulate CGRP receptor signaling.","volume":"153","author":"Egea","year":"2012","journal-title":"Endocrinology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"31438","DOI":"10.1074\/jbc.M005604200","article-title":"CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors.","volume":"275","author":"Evans","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(19)31946-4","article-title":"Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.","volume":"394","author":"Ferrari","year":"2019","journal-title":"Lancet"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1111\/bcp.14096","article-title":"Population pharmacokinetic modelling and simulation of fremanezumab in healthy subjects and patients with migraine.","volume":"85","author":"Fiedler-Kelly","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/305534a0","article-title":"Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide.","volume":"305","author":"Fisher","year":"1983","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0301-0082(94)e0017-b","article-title":"Calcitonin gene-related peptide and tachykinins in relation to local sensory control of cardiac contractility and coronary vascular tone.","volume":"569","author":"Franco-Cereceda","year":"1988","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"B51","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/BF00634231","article-title":"Calcitonin gene-related peptide (CGRP) and capsaicin-induced stimulation of heart contractile rate and force.","volume":"331","author":"Franco-Cereceda","year":"1985","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj3450233","article-title":"Distinct signalling pathways mediate the cAMP response element (CRE)-dependent activation of the calcitonin gene-related peptide gene promoter by cAMP and nerve growth factor.","author":"Freeland","year":"2000","journal-title":"Biochem. J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/ETLS20200018","article-title":"Fremanezumab: a disease-specific option for the preventive treatment of migraine, including difficult-to-treat migraine.","volume":"4","author":"Friedman","year":"2020","journal-title":"Emerg. Top. Life Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/00004872-199102000-00013","article-title":"The antihypertensive effect of calcitonin gene-related peptide in rats with norepinephrine- and angiotensin II-induced hypertension.","volume":"9","author":"Fujioka","year":"1991","journal-title":"J. Hypertens."},{"key":"B55","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1046\/j.1468-2982.1995.1505384.x","article-title":"Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally.","volume":"15","author":"Gallai","year":"1995","journal-title":"Cephalalgia"},{"key":"B56","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1161\/01.hyp.29.1.248","article-title":"Calcitonin gene-related peptide is a depressor in NG-nitro-L-arginine methyl ester-induced hypertension during pregnancy.","volume":"29","author":"Gangula","year":"1997","journal-title":"Hypertension"},{"key":"B57","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1161\/01.hyp.35.1.470","article-title":"Increased blood pressure in alpha-calcitonin gene-related peptide\/calcitonin gene knockout mice.","volume":"35","author":"Gangula","year":"2000","journal-title":"Hypertension"},{"key":"B58","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201702151","article-title":"TRPA1-dependent calcium transients and CGRP release in DRG neurons require extracellular calcium.","volume":"219","author":"Gebhardt","year":"2020","journal-title":"J. Cell Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/cvr\/24.3.239","article-title":"Improved cardiac performance with human calcitonin gene related peptide in patients with congestive heart failure.","volume":"24","author":"Gennari","year":"1990","journal-title":"Cardiovasc. Res."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/polym12102417","article-title":"Alginate: from food industry to biomedical applications and management of metabolic disorders.","volume":"12","author":"Gheorghita Puscaselu","year":"2020","journal-title":"Polymers"},{"key":"B61","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0304-3940(85)90050-3","article-title":"Co-localization of calcitonin gene-related peptide-like immunoreactivity with substance P in cutaneous, vascular and visceral sensory neurons of guinea pigs.","volume":"57","author":"Gibbins","year":"1985","journal-title":"Neurosci. Lett."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1523\/JNEUROSCI.04-12-03101.1984","article-title":"Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species.","volume":"4","author":"Gibson","year":"1984","journal-title":"J. Neurosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa1813440","article-title":"Trial of Galcanezumab in prevention of episodic cluster headache.","volume":"381","author":"Goadsby","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.410230214","article-title":"Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system.","volume":"23","author":"Goadsby","year":"1988","journal-title":"Ann. Neurol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.","volume":"28","author":"Goadsby","year":"1990","journal-title":"Ann. Neurol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1056\/nejmoa1705848","article-title":"A controlled trial of erenumab for episodic migraine.","volume":"377","author":"Goadsby","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e2487","DOI":"10.1212\/WNL.0000000000010600","article-title":"Long-term safety, tolerability, and efficacy of fremanezumab in migraine: a randomized study.","volume":"95","author":"Goadsby","year":"2020","journal-title":"Neurology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0014-2999(92)90069-g","article-title":"Nitric oxide synthesis inhibitors attenuate calcitonin gene-related peptide endothelium-dependent vasorelaxation in rat aorta.","volume":"212","author":"Gray","year":"","journal-title":"Eur. J. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1476-5381.1992.tb14508.x","article-title":"Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide.","volume":"107","author":"Gray","year":"","journal-title":"Br. J. Pharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/01.res.73.3.579","article-title":"Peptidergic innervation of human epicardial coronary arteries.","volume":"73","author":"Gulbenkian","year":"1993","journal-title":"Circ. Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1177\/0333102410368444","article-title":"Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura.","volume":"30","author":"Hansen","year":"2010","journal-title":"Cephalalgia"},{"key":"B72","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/head.13064","article-title":"CGRP and its receptors.","volume":"57","author":"Hay","year":"2017","journal-title":"Headache"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1124\/mol.106.027953","article-title":"Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors\u2013the role of receptor activity modifying protein 1.","volume":"70","author":"Hay","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/sj.bjp.0705472","article-title":"CL\/RAMP2 and CL\/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS.","volume":"140","author":"Hay","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1146\/annurev-pharmtox-010715-103120","article-title":"Receptor activity-modifying proteins (RAMPs): new insights and roles.","volume":"56","author":"Hay","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"29575","DOI":"10.1074\/jbc.M102722200","article-title":"Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins.","volume":"276","author":"Hilairet","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/sj.bjp.0705040","article-title":"The role of the 8-18 helix of CGRP8-37 in mediating high affinity binding to CGRP receptors; coulombic and steric interactions.","volume":"138","author":"Howitt","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"B78","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s40265-018-1004-5","article-title":"Fremanezumab: first global approval.","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"B79","doi-asserted-by":"publisher","first-page":"H1291","DOI":"10.1152\/ajpheart.00749.2007","article-title":"Deletion of the mouse alpha-calcitonin gene-related peptide gene increases the vulnerability of the heart to ischemia-reperfusion injury.","volume":"294","author":"Huang","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0006-8993(86)90423-3","article-title":"Autoradiographic localization of calcitonin gene-related peptide binding sites in human and rat brains.","volume":"374","author":"Inagaki","year":"1986","journal-title":"Brain Res."},{"key":"B81","first-page":"403","article-title":"Role of calcitonin gene-related peptide-containing nerves in the vascular adrenergic neurotransmission.","volume":"252","author":"Kawasaki","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01249","article-title":"The role of calcitonin gene related peptide (CGRP) in neurogenic vasodilation and its cardioprotective effects.","volume":"9","author":"Kee","year":"2018","journal-title":"Front. Physiol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1111\/j.1460-9568.2009.06747.x","article-title":"TRPV1 controls acid- and heat-induced calcitonin gene-related peptide release and sensitization by bradykinin in the isolated mouse trachea.","volume":"29","author":"Kichko","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.602952","article-title":"A novel alginate-based delivery system for the prevention and treatment of pressure-overload induced heart failure.","volume":"11","author":"Kumar","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00821","article-title":"Protective role of alpha-calcitonin gene-related peptide in cardiovascular diseases.","volume":"10","author":"Kumar","year":"","journal-title":"Front. Physiol."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14269","article-title":"Alpha-calcitonin gene-related peptide prevents pressure-overload induced heart failure: role of apoptosis and oxidative stress.","volume":"7","author":"Kumar","year":"","journal-title":"Physiol. Rep."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s40265-018-1002-7","article-title":"Galcanezumab: first global approval.","volume":"78","author":"Lamb","year":"2018","journal-title":"Drugs"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/0002-8703(92)90054-y","article-title":"Calcitonin gene-related peptide in patients with and without early reperfusion after acute myocardial infarction.","volume":"124","author":"Lechleitner","year":"1992","journal-title":"Am. Heart J."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/cne.21607","article-title":"Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.","volume":"507","author":"Lennerz","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.regpep.2013.06.008","article-title":"Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure.","volume":"185","author":"Li","year":"2013","journal-title":"Regul. Pept."},{"key":"B91","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00004872-200501000-00020","article-title":"Development of angiotensin II-induced hypertension: role of CGRP and its receptor.","volume":"23","author":"Li","year":"2005","journal-title":"J. Hypertens."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1097\/01.hjh.0000125409.50839.f1","article-title":"Activation of the renin-angiotensin system in alpha-calcitonin gene-related peptide\/calcitonin gene knockout mice.","volume":"22","author":"Li","year":"2004","journal-title":"J. Hypertens."},{"key":"B93","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1139\/y10-067","article-title":"Reversal of isoprenaline-induced cardiac remodeling by rutaecarpine via stimulation of calcitonin gene-related peptide production.","volume":"88","author":"Li","year":"2010","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0306-4522(89)90310-2","article-title":"Neuropeptide expression in cultures of adult sensory neurons: modulation of substance P and calcitonin gene-related peptide levels by nerve growth factor.","volume":"33","author":"Lindsay","year":"1989","journal-title":"Neuroscience"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1097\/01.ccm.0000134404.63292.71","article-title":"Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes.","volume":"32","author":"Linscheid","year":"2004","journal-title":"Crit. Care Med."},{"key":"B96","doi-asserted-by":"crossref","first-page":"e1365","DOI":"10.1212\/WNL.0000000000009169","article-title":"Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2.","volume":"94","author":"Lipton","year":"2020","journal-title":"Neurology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.regpep.2011.05.014","article-title":"Calcitonin gene-related peptide prevents blood-brain barrier injury and brain edema induced by focal cerebral ischemia reperfusion.","volume":"171","author":"Liu","year":"2011","journal-title":"Regul. Pept."},{"key":"B98","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.3892\/etm.2017.5126","article-title":"Calcitonin gene-related peptide has protective effect on brain injury induced by heat stroke in rats.","volume":"14","author":"Lu","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1006\/mcne.1999.0767","article-title":"Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development.","volume":"14","author":"Lu","year":"1999","journal-title":"Mol. Cell. Neurosci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/BF00506198","article-title":"Capsaicin-induced stimulation of the guinea-pig atrium. Involvement of a novel sensory transmitter or a direct action on myocytes?","volume":"325","author":"Lundberg","year":"1984","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.pedneo.2015.10.012","article-title":"Calcitonin gene-related peptide downregulates expression of inducible nitride oxide synthase and caspase-3 after intestinal ischemia-reperfusion injury in rats.","volume":"57","author":"Luo","year":"2016","journal-title":"Pediatr. Neonatol."},{"key":"B102","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-2999(90)90422-3","article-title":"Biological activity of N-terminal fragments of calcitonin gene-related peptide.","volume":"179","author":"Maggi","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90040-c","article-title":"Plasma CGRP in acute myocardial infarction.","volume":"335","author":"Mair","year":"1990","journal-title":"Lancet"},{"key":"B104","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/0196-9781(88)90073-3","article-title":"Autoradiographic localization of calcitonin gene-related peptide (CGRP) binding sites in human and guinea pig lung.","volume":"9","author":"Mak","year":"1988","journal-title":"Peptides"},{"key":"B105","doi-asserted-by":"publisher","first-page":"14294","DOI":"10.1074\/jbc.M109661200","article-title":"Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists.","volume":"277","author":"Mallee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s40265-018-0944-0","article-title":"Erenumab: first global approval.","volume":"78","author":"Markham","year":"2018","journal-title":"Drugs"},{"key":"B107","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1161\/HYPERTENSIONAHA.112.201434","article-title":"A role for TRPV1 in influencing the onset of cardiovascular disease in obesity.","volume":"61","author":"Marshall","year":"2013","journal-title":"Hypertension"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1097\/00004872-199210120-00010","article-title":"Plasma calcitonin gene-related peptide levels in patients with various hypertensive diseases.","volume":"10","author":"Masuda","year":"1992","journal-title":"J. Hypertens."},{"key":"B109","doi-asserted-by":"publisher","first-page":"7366","DOI":"10.1073\/pnas.85.19.7366","article-title":"Differential effect of alpha-latrotoxin on exocytosis from small synaptic vesicles and from large dense-core vesicles containing calcitonin gene-related peptide at the frog neuromuscular junction.","volume":"85","author":"Matteoli","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1152\/jappl.1989.67.3.1265","article-title":"Calcitonin gene-related peptide vasodilation of human pulmonary vessels.","volume":"67","author":"McCormack","year":"1989","journal-title":"J. Appl. Physiol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1073\/pnas.83.15.5731","article-title":"Calcitonin gene-related peptide: functional role in cerebrovascular regulation.","volume":"83","author":"McCulloch","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B112","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"B113","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/HYPERTENSIONAHA.110.169128","article-title":"Calcitonin gene-related peptide terminates long-lasting vasopressor responses to endothelin 1 in vivo.","volume":"58","author":"Meens","year":"2011","journal-title":"Hypertension"},{"key":"B114","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1476-5381.2011.01774.x","article-title":"G-protein betagamma subunits in vasorelaxing and anti-endothelinergic effects of calcitonin gene-related peptide.","volume":"166","author":"Meens","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1523\/JNEUROSCI.5490-08.2009","article-title":"Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential.","volume":"29","author":"Meng","year":"2009","journal-title":"J. Neurosci."},{"key":"B116","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.neuroscience.2016.04.046","article-title":"Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies.","volume":"328","author":"Miller","year":"2016","journal-title":"Neuroscience"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086570","article-title":"Impact of the controlled release of a connexin 43 peptide on corneal wound closure in an STZ model of type I diabetes.","volume":"9","author":"Moore","year":"2014","journal-title":"PLoS One"},{"key":"B118","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1210\/endo.140.6.6930","article-title":"An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3.","volume":"140","author":"Muff","year":"1999","journal-title":"Endocrinology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0306-4522(88)90018-8","article-title":"Differential expression of alpha-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the rat.","volume":"25","author":"Mulderry","year":"1988","journal-title":"Neuroscience"},{"key":"B120","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1254\/jjp.42.175","article-title":"Binding sites of calcitonin gene-related peptide (CGRP): abundant occurrence in visceral organs.","volume":"42","author":"Nakamuta","year":"1986","journal-title":"Jpn. J. Pharmacol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/344770a0","article-title":"Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels.","volume":"344","author":"Nelson","year":"1990","journal-title":"Nature"},{"key":"B122","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/323809a0","article-title":"Calcitonin gene-related peptide regulates muscle acetylcholine receptor synthesis.","volume":"323","author":"New","year":"1986","journal-title":"Nature"},{"key":"B123","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejphar.2016.01.003","article-title":"Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1.","volume":"773","author":"Nilsson","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/00004647-200205000-00014","article-title":"Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature.","volume":"22","author":"Oliver","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B125","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejphar.2012.05.053","article-title":"The role of transient receptor potential ankyrin 1 (TRPA1) receptor activation in hydrogen-sulphide-induced CGRP-release and vasodilation.","volume":"689","author":"Pozsgai","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"B126","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1476-5381.2009.00541.x","article-title":"Structure-function relationships of the N-terminus of receptor activity-modifying proteins.","volume":"159","author":"Qi","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/304129a0","article-title":"Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing.","volume":"304","author":"Rosenfeld","year":"1983","journal-title":"Nature"},{"key":"B128","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0940-9602(01)80176-X","article-title":"Expression of vasoactive intestinal polypeptide and calcitonin gene-related peptide in human stellate ganglia after acute myocardial infarction.","volume":"183","author":"Roudenok","year":"2001","journal-title":"Ann. Anat."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2019.183174","article-title":"Receptor component protein, an endogenous allosteric modulator of family B G protein coupled receptors.","volume":"1862","author":"Routledge","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/0196-9781(92)90067-d","article-title":"CGRP antagonist activity of short C-terminal fragments of human alpha CGRP, CGRP(23-37) and CGRP(19-37).","volume":"13","author":"Rovero","year":"1992","journal-title":"Peptides"},{"key":"B131","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology.","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol. Rev."},{"key":"B132","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/HYPERTENSIONAHA.109.148171","article-title":"Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates angiotensin-induced hypertension.","volume":"55","author":"Sabharwal","year":"2010","journal-title":"Hypertension"},{"key":"B133","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/dneu.20358","article-title":"Costorage of BDNF and neuropeptides within individual dense-core vesicles in central and peripheral neurons.","volume":"67","author":"Salio","year":"2007","journal-title":"Dev. Neurobiol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tips.2020.01.009","article-title":"Dawn of a new RAMPage.","volume":"41","author":"Serafin","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/0306-4522(86)90137-5","article-title":"Localization of binding sites for calcitonin gene-related peptide in rat brain by in vitro autoradiography.","volume":"19","author":"Sexton","year":"1986","journal-title":"Neuroscience"},{"key":"B136","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/0002-9149(91)90531-o","article-title":"Effects of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal blood flow and hormone levels in congestive heart failure.","volume":"67","author":"Shekhar","year":"1991","journal-title":"Am. J. Cardiol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1124\/jpet.115.227793","article-title":"Pharmacologic characterization of AMG 334, a potent and selective human monoclonal antibody against the calcitonin gene-related peptide receptor.","volume":"356","author":"Shi","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B138","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa1709038","article-title":"Fremanezumab for the preventive treatment of chronic migraine.","volume":"377","author":"Silberstein","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.113.02517","article-title":"An ongoing role of alpha-calcitonin gene-related peptide as part of a protective network against hypertension, vascular hypertrophy, and oxidative stress.","volume":"63","author":"Smillie","year":"2014","journal-title":"Hypertension"},{"key":"B140","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.clinthera.2020.11.007","article-title":"Eptinezumab for the prevention of episodic migraine: sustained effect through 1 year of treatment in the PROMISE-1 study.","volume":"42","author":"Smith","year":"2020","journal-title":"Clin. Ther."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.transproceed.2009.03.056","article-title":"Pretreatment with calcitonin gene-related peptide attenuates hepatic ischemia\/reperfusion injury in rats.","volume":"41","author":"Song","year":"2009","journal-title":"Transplant. Proc."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/jamaneurol.2018.1212","article-title":"Evaluation of galcanezumab for the prevention of episodic migraine: the EVOLVE-1 randomized clinical trial.","volume":"75","author":"Stauffer","year":"2018","journal-title":"JAMA Neurol."},{"key":"B143","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0014-5793(85)80820-6","article-title":"A second human calcitonin\/CGRP gene.","volume":"183","author":"Steenbergh","year":"1985","journal-title":"FEBS Lett."},{"key":"B144","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0014-5793(86)81091-2","article-title":"Structure and expression of the human calcitonin\/CGRP genes.","volume":"209","author":"Steenbergh","year":"1986","journal-title":"FEBS Lett."},{"key":"B145","doi-asserted-by":"publisher","first-page":"11398","DOI":"10.1021\/bi020279r","article-title":"The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor.","volume":"41","author":"Steiner","year":"2002","journal-title":"Biochemistry"},{"key":"B146","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.npep.2005.11.005","article-title":"Release of calcitonin gene-related peptide from the isolated mouse heart: methodological validation of a new model.","volume":"40","author":"Strecker","year":"2006","journal-title":"Neuropeptides"},{"key":"B147","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1042\/cs0700389","article-title":"Human calcitonin gene related peptide: a potent endogenous vasodilator in man.","volume":"70","author":"Struthers","year":"1986","journal-title":"Clin. Sci."},{"key":"B148","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/01.HYP.21.6.1010","article-title":"Calcitonin gene-related peptide gene expression in the spontaneously hypertensive rat.","volume":"21","author":"Supowit","year":"1993","journal-title":"Hypertension"},{"key":"B149","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/01.HYP.0000151130.34874.fa","article-title":"Calcitonin gene-related peptide protects against hypertension-induced heart and kidney damage.","volume":"45","author":"Supowit","year":"2005","journal-title":"Hypertension"},{"key":"B150","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/01.hyp.37.2.728","article-title":"Nerve growth factor enhances calcitonin gene-related peptide expression in the spontaneously hypertensive rat.","volume":"37","author":"Supowit","year":"2001","journal-title":"Hypertension"},{"key":"B151","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1161\/01.hyp.29.4.945","article-title":"Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat.","volume":"29","author":"Supowit","year":"1997","journal-title":"Hypertension"},{"key":"B152","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1161\/01.hyp.31.1.391","article-title":"Calcitonin gene-related peptide is a depressor in subtotal nephrectomy hypertension.","volume":"31","author":"Supowit","year":"1998","journal-title":"Hypertension"},{"key":"B153","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.regpep.2010.12.006","article-title":"Bradykinin and prostaglandin E(1) regulate calcitonin gene-related peptide expression in cultured rat sensory neurons.","volume":"167","author":"Supowit","year":"2011","journal-title":"Regul. Pept."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1161\/01.hyp.26.6.1177","article-title":"Regulation of neuronal calcitonin gene-related peptide expression. Role of increased blood pressure.","volume":"26","author":"Supowit","year":"","journal-title":"Hypertension"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1161\/01.hyp.25.6.1333","article-title":"Enhanced neuronal expression of calcitonin gene-related peptide in mineralocorticoid-salt hypertension.","volume":"25","author":"Supowit","year":"","journal-title":"Hypertension"},{"key":"B156","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1474-4422(17)30083-2","article-title":"Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.","volume":"16","author":"Tepper","year":"2017","journal-title":"Lancet Neurol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"H681","DOI":"10.1152\/ajpheart.1992.263.3.H681","article-title":"CGRP and somatostatin modulate chronic hypoxic pulmonary hypertension.","volume":"263","author":"Tjen","year":"1992","journal-title":"Am. J. Physiol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/s0008-6363(00)00291-1","article-title":"Cardiac fibroblasts are major production and target cells of adrenomedullin in the heart in vitro.","volume":"49","author":"Tomoda","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"B159","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3892\/ijmm.8.3.261","article-title":"Calcitonin gene-related peptide (CGRP), acting via CGRP type 1 receptors, inhibits potassium-stimulated aldosterone secretion and enhances basal catecholamine secretion from rat adrenal gland.","volume":"8","author":"Tortorella","year":"2001","journal-title":"Int. J. Mol. Med."},{"key":"B160","doi-asserted-by":"publisher","first-page":"16702","DOI":"10.1073\/pnas.0705974104","article-title":"Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice.","volume":"104","author":"Tsujikawa","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B161","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1124\/mol.106.024257","article-title":"A critical role for the short intracellular C terminus in receptor activity-modifying protein function.","volume":"70","author":"Udawela","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0167-0115(86)90071-6","article-title":"Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects.","volume":"15","author":"Uddman","year":"1986","journal-title":"Regul. Pept."},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-019-0768-y","article-title":"CGRP antagonists for the treatment of chronic migraines: a comprehensive review.","volume":"23","author":"Urits","year":"2019","journal-title":"Curr. Pain Headache Rep."},{"key":"B164","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/s0149-7634(96)00023-1","article-title":"Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors.","volume":"21","author":"van Rossum","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B165","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.tips.2010.06.006","article-title":"Regulation of signal transduction by calcitonin gene-related peptide receptors.","volume":"31","author":"Walker","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"B166","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/acn3.197","article-title":"A second trigeminal CGRP receptor: function and expression of the AMY1 receptor.","volume":"2","author":"Walker","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/0333102417691762","article-title":"CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured.","volume":"38","author":"Walker","year":"2018","journal-title":"Cephalalgia"},{"key":"B168","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/s0165-5728(02)00221-7","article-title":"Production and secretion of calcitonin gene-related peptide from human lymphocytes.","volume":"130","author":"Wang","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4103\/1673-5374.243719","article-title":"Effects of TRPA1 activation and inhibition on TRPA1 and CGRP expression in dorsal root ganglion neurons.","volume":"14","author":"Wang","year":"2019","journal-title":"Neural Regen. Res."},{"key":"B170","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/0333102417728873","article-title":"Distribution of CGRP and CGRP receptor components in the rat brain.","volume":"39","author":"Warfvinge","year":"2019","journal-title":"Cephalalgia"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/bph.12072","article-title":"Structure-activity relationships for alpha-calcitonin gene-related peptide.","volume":"170","author":"Watkins","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/14728222.2020.1724285","article-title":"Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting.","volume":"24","author":"Wattiez","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"B173","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0167-5273(88)90313-0","article-title":"Calcitonin gene-related peptide and its specific binding sites in the cardiovascular system of rat.","volume":"20","author":"Wimalawansa","year":"1988","journal-title":"Int. J. Cardiol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.regpep.2004.12.008","article-title":"Calcitonin gene related peptide mediates cardioprotection by remote preconditioning.","volume":"127","author":"Wolfrum","year":"2005","journal-title":"Regul. Pept."},{"key":"B175","first-page":"588","article-title":"Effects of calcitonin gene-related peptide and BIBN4096BS on myocardial ischemia in anesthetized rats.","volume":"22","author":"Wu","year":"2001","journal-title":"Acta Pharmacol. Sin."},{"key":"B176","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejpb.2010.09.016","article-title":"Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.","volume":"77","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B177","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.athoracsur.2007.03.067","article-title":"Effect of prepro-calcitonin gene-related peptide-expressing endothelial progenitor cells on pulmonary hypertension.","volume":"84","author":"Zhao","year":"2007","journal-title":"Ann. Thorac. Surg."},{"key":"B178","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ijcard.2011.04.009","article-title":"Up-regulation of calcitonin gene-related peptide protects streptozotocin-induced diabetic hearts from ischemia\/reperfusion injury.","volume":"156","author":"Zheng","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.biopha.2018.01.065","article-title":"Genetic ablation of TRPV1 exacerbates pressure overload-induced cardiac hypertrophy.","volume":"99","author":"Zhong","year":"2018","journal-title":"Biomed. Pharmacother."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.826122\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T09:47:04Z","timestamp":1644572824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.826122\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":179,"alternative-id":["10.3389\/fphys.2022.826122"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2022.826122","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]},"article-number":"826122"}}